Fresenius Medical Care AG KGaA EBIT Margin 2010-2023 | FMS
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Fresenius Medical Care AG KGaA (FMS) over the last 10 years. The current EBIT profit margin for Fresenius Medical Care AG KGaA as of December 31, 2023 is .
| Fresenius Medical Care AG KGaA EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2023-12-31 | $21.06B | $1.48B | 7.04% |
| 2023-09-30 | $20.82B | $1.39B | 6.66% |
| 2023-06-30 | $20.58B | $1.51B | 7.33% |
| 2023-03-31 | $20.38B | $1.48B | 7.27% |
| 2022-12-31 | $20.44B | $1.59B | 7.79% |
| 2022-09-30 | $20.63B | $1.74B | 8.44% |
| 2022-06-30 | $20.73B | $1.86B | 8.97% |
| 2022-03-31 | $20.87B | $2.01B | 9.63% |
| 2021-12-31 | $20.84B | $2.19B | 10.51% |
| 2021-09-30 | $20.79B | $2.24B | 10.76% |
| 2021-06-30 | $20.71B | $2.38B | 11.50% |
| 2021-03-31 | $20.53B | $2.59B | 12.63% |
| 2020-12-31 | $20.40B | $2.63B | 12.90% |
| 2020-09-30 | $20.21B | $2.76B | 13.65% |
| 2020-06-30 | $19.97B | $2.68B | 13.43% |
| 2020-03-31 | $19.83B | $2.55B | 12.83% |
| 2019-12-31 | $19.57B | $2.54B | 12.99% |
| 2019-09-30 | $19.40B | $2.55B | 13.15% |
| 2019-06-30 | $19.21B | $2.50B | 13.02% |
| 2019-03-31 | $19.35B | $3.59B | 18.53% |
| 2018-12-31 | $19.54B | $3.59B | 18.36% |
| 2018-09-30 | $19.87B | $3.51B | 17.68% |
| 2018-06-30 | $20.25B | $3.62B | 17.86% |
| 2018-03-31 | $20.14B | $2.59B | 12.84% |
| 2017-12-31 | $20.10B | $2.67B | 13.28% |
| 2017-09-30 | $19.55B | $2.84B | 14.51% |
| 2017-06-30 | $19.05B | $2.79B | 14.66% |
| 2017-03-31 | $18.55B | $2.79B | 15.04% |
| 2016-12-31 | $17.91B | $2.64B | 14.72% |
| 2016-09-30 | $17.57B | $2.51B | 14.30% |
| 2016-06-30 | $17.20B | $2.46B | 14.28% |
| 2016-03-31 | $16.98B | $2.36B | 13.91% |
| 2015-12-31 | $16.74B | $2.33B | 13.90% |
| 2015-09-30 | $16.71B | $2.33B | 13.93% |
| 2015-06-30 | $16.59B | $2.30B | 13.89% |
| 2015-03-31 | $16.23B | $2.31B | 14.25% |
| 2014-12-31 | $15.83B | $2.25B | 14.24% |
| 2014-09-30 | $15.38B | $2.25B | 14.63% |
| 2014-06-30 | $14.93B | $2.21B | 14.81% |
| 2014-03-31 | $14.71B | $2.19B | 14.87% |
| 2013-12-31 | $14.61B | $2.23B | 15.26% |
| 2013-09-30 | $14.45B | $2.12B | 14.70% |
| 2013-06-30 | $14.20B | $2.14B | 15.03% |
| 2013-03-31 | $14.02B | $2.16B | 15.43% |
| 2012-12-31 | $13.80B | $2.16B | 15.68% |
| 2012-09-30 | $13.42B | $2.19B | 16.31% |
| 2012-06-30 | $13.24B | $2.15B | 16.27% |
| 2012-03-31 | $13.01B | $2.10B | 16.11% |
| 2011-12-31 | $12.80B | $2.05B | 15.98% |
| 2011-09-30 | $12.64B | $2.01B | 15.90% |
| 2011-06-30 | $12.46B | $1.97B | 15.85% |
| 2011-03-31 | $12.21B | $1.94B | 15.88% |
| 2010-12-31 | $12.05B | $1.92B | 15.96% |
| 2010-09-30 | $11.92B | $1.87B | 15.71% |
| 2010-06-30 | $11.75B | $1.83B | 15.58% |
| 2010-03-31 | $11.57B | $1.78B | 15.42% |
| 2009-12-31 | $11.25B | $1.76B | 15.61% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $11.795B | $21.053B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.951B | 26.53 |
| Intuitive Surgical (ISRG) | United States | $133.132B | 80.20 |
| Edwards Lifesciences (EW) | United States | $52.025B | 33.89 |
| DexCom (DXCM) | United States | $49.242B | 74.90 |
| IQVIA Holdings (IQV) | United States | $42.631B | 25.28 |
| IDEXX Laboratories (IDXX) | United States | $41.469B | 49.58 |
| Alcon (ALC) | Switzerland | $38.841B | 28.64 |
| STERIS (STE) | Ireland | $20.148B | 23.85 |
| Waters (WAT) | United States | $18.463B | 26.49 |
| Hologic (HOLX) | United States | $17.835B | 19.68 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.800B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.341B | 85.27 |
| Sysmex ADR (SSMXY) | Japan | $10.000B | 31.36 |
| Teleflex (TFX) | United States | $9.736B | 15.29 |
| Penumbra (PEN) | United States | $7.923B | 97.80 |
| Masimo (MASI) | United States | $7.204B | 40.40 |
| Globus Medical (GMED) | United States | $6.843B | 21.70 |
| Glaukos (GKOS) | United States | $4.993B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.671B | 22.18 |
| TransMedics (TMDX) | United States | $3.012B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.996B | 19.76 |
| PROCEPT BioRobotics (PRCT) | United States | $2.664B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.629B | 18.04 |
| Nihon Kohden (NHNKY) | Japan | $2.417B | 20.44 |
| Tandem Diabetes Care (TNDM) | United States | $2.275B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.228B | 9.14 |
| Inari Medical (NARI) | United States | $2.227B | 384.20 |
| RxSight (RXST) | United States | $1.952B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.716B | 0.00 |
| Veracyte (VCYT) | United States | $1.450B | 0.00 |
| OPKO Health (OPK) | United States | $0.878B | 0.00 |
| Artivion (AORT) | United States | $0.847B | 97.95 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.836B | 15.47 |
| Paragon 28 (FNA) | United States | $0.730B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.720B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.697B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.642B | 0.00 |
| SiBone (SIBN) | United States | $0.598B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.557B | 18.90 |
| IRadimed (IRMD) | United States | $0.530B | 30.78 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.486B | 0.00 |
| Nevro (NVRO) | United States | $0.415B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.397B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.394B | 0.00 |
| NeuroPace (NPCE) | United States | $0.385B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.340B | 11.44 |
| CVRx (CVRX) | United States | $0.317B | 0.00 |
| AxoGen (AXGN) | United States | $0.290B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.270B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.262B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.233B | 0.00 |
| Accuray (ARAY) | United States | $0.217B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.192B | 0.00 |
| 908 Devices (MASS) | United States | $0.187B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.184B | 9.89 |
| Alpha Tau Medical (DRTS) | Israel | $0.168B | 0.00 |
| Inogen (INGN) | United States | $0.160B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.142B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.135B | 0.00 |
| Neuronetics (STIM) | United States | $0.105B | 0.00 |
| Envoy Medical (COCH) | United States | $0.102B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.100B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.098B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.069B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.061B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 113.67 |
| Vasomedical (VASO) | United States | $0.053B | 9.47 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| InspireMD (NSPR) | Israel | $0.047B | 0.00 |
| DarioHealth (DRIO) | United States | $0.044B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.041B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.016B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.016B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |